Volv applies its proprietary methods to the problem of identifying patients at risk of any disease that is difficult to diagnose, thereby helping clinicians with their everyday workflows. We are based in Switzerland with a multinational team and with an international presence.
Products, services, technology
inTrigue: Volv's methodology for finding patients with difficult to diagnose and rare diseases, inTrigue is a new way of building computational models using machine learning to detect undiagnosed rare and orphan disease patients in population-scale databases such as electronic health records.
- https://www.volv.global/
- +41 79 552 79 11
